| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 27, 2024 | Quiet Light Announces Attendance at the Business of Software Conference in Raleigh, North Carolina, in September | Quiet Light is Excited to Empower Business Owners and Entrepreneurs with the Skills and Resources to Maximize the Value of their Software Businesses INVER GROVE HEIGHTS, MN, UNITED STATES, May 27, 2024 /EINPresswire.com/ -- This September, ... |
| Jun 16, 2021 | How one Durham-based foundation is investing in North Carolina’s entrepreneurs and growing the state’s innovation footprint | Thom Ruhe and Roy Cooper. NC IDEA
The NC IDEA foundation supports entrepreneurship and economic development across North Carolina.
Using grants, seed funding, mentoring, and other programs, NC IDEA helps entrepreneurs directly.
Some initiat... |
| Mar 31, 2015 | FundingFest: These Chicago Startups Raised Millions This March | At the end of every month, we take a look back at all of the Chicago startups that raised millions over the past thirty days. It's FundingFest time!
Here are a couple highlights:
In March, three EdTech startups raised a combined $4.9M, with... |
| Mar 5, 2015 | Quality over compliance? FDA’s shaking it up. #CEDLSC15 | The basic idea here, he said, is to emphasize quality over compliance – so that better drugs will disseminate on the market without having to worry too deeply about stumbling in the regulatory process.
There’s been a greater shift to engage... |
| Mar 4, 2015 | The secret sauce of venture philanthropy: Passion and forced collaboration #CEDLSC15 | Campbell spoke about the disruptive nature of venture philanthropy and patient advocacy on a panel at this week’s CED Life Sciences conference in Raleigh. He was joined by two others in this space – Ilan Ganot of Solid Ventures and Josh Som... |
| Mar 3, 2015 | Angel investor involvement growing in North Carolina life sciences startup scene #CEDLSC15 | “There’s been an uptick in undisclosed investors, and growth in syndicated angel investor funds,” Rose said.
Notably, the majority of investment dollars come from outside North Carolina, with a huge chunk in California – though this include... |
| Nov 7, 2014 | Okta Catches SpydrSafe In Its Enterprise Web | Update: Okta has still not explicitly confirmed the acquisition of SpydrSafe, but its cofounder today retweeted our story about the sale after Okta unveiled a new Mobility Management service. That new product is much of what I describe belo... |
| Jun 4, 2014 | CED Releases 2013 Innovators Report, Finds 108 Unique Funders Made Investments in North Carolina Companies | The Council for Entrepreneurial Development (CED), the Southeast’s largest entrepreneurial support organization, has released its Innovators Report, showing that entrepreneurial companies in North Carolina collectively raised more than $461... |
| Feb 27, 2013 | 4 life sciences CEOs on lessons learned the hard way | Tim Willis, president, CEO and co-founder, TearScience: “We were out raising a series C, and we thought we had done our due diligence on the firms we were working with, and we assumed incorrectly that they had money to (do deals). I had fou... |
| Jul 15, 2012 | CED Program Director Dhruv Patel On North Carolina’s Startup Scene | Over the past week, we took TechCrunch on the road for our Southeast Meetup tour. Of the five cities we visited in seven days, Durham had one of the hungriest entrepreneurial scenes. The majority of the city is relatively run-down, aside fr... |
| Feb 24, 2012 | Sanofi’s Viehbacher thinks Big Pharma will seek earlier-stage deals. Here’s why | But just as important, the agreement provides an exit for Warp Drive’s investors. The partnership is structured in a way that allows Third Rock to force Sanofi to buy the company if certain performance criteria are met, Viehbacher explained... |
| Feb 22, 2012 | J&J’s Alex Gorsky on healthcare, globalization and changes to come | Gorsky’s Feb. 16 address to the CED conference was likely his last public appearance before he was named Weldon’s successor. In that speech, Gorsky tapped his career in healthcare to note the industry changes he sees. He said that with a di... |
| Feb 20, 2012 | Are new life science investors eyeing Research Triangle Park? | Plus, the recent CED Life Science Conference had a series of new investor faces in the audience, as well as some prodigal sons. A few I spoke with said they were there because they thought there were deals to be done that the typical Park i... |
| Feb 17, 2012 | Make a life sciences conference invite only? Open to everyone? Both? | Most life sciences events have an invitation-only event or two. But at the CED Life Science Conference this week there were literally two conferences going on at once: one that everyone could attend and constant, ongoing invitation-only sec... |
| Feb 16, 2012 | Life sciences companies make pharma pitches, hope for hits with investors | Heat Bio. Heat’s lead drug program is an experimental lung cancer treatment in phase 2 clinical trials. Heat Bio’s proprietary technology reprograms tumor cells to pump out antigens to fight disease. CEO Jeff Wolf said that when the company... |
| Feb 16, 2012 | If TearScience does a healthcare IPO, it may be in China | “We are looking at it as a vehicle for liquidity,” Willis said.
Willis didn’t have many other details, only that TearScience is talking with investment bankers now and that they are very early in exploring the overseas IPO approach. He ment... |
| Feb 15, 2012 | Pharmas, medical device makers set to pitch at CED Life Science conference | A total of 16 companies are scheduled to make presentations, split evenly between pharmaceuticals and medical devices. Here’s a quick rundown of the presenting companies, all of whom are either based in North Carolina’s Research Triangle or... |
| Feb 7, 2012 | Annual CED Life Science Conference features emerging life science companies | This post is sponsored by CED.
CED, the Southeast’s largest entrepreneurial support organization, will feature the Biopharma and Medtech Emerging Company Showcase, showcasing the most promising emerging companies in North Carolina, which wi... |
| Dec 8, 2011 | 4 tips for life sciences companies seeking foundation funding | “Our job is to put the ball in the air, throw the long ball,” he said.
Angel investors and venture capitalists are not the only path for companies looking to traverse the so-called valley of death. Life sciences companies have a funding alt... |
| May 11, 2011 | CRO Clinipace raises $8M; M&A announcement expected | A May 9 filing with the U.S. Securities and Exchange Commission shows that Clinipace has raised $3.3 million in debt financing from a sale that began on May 5. In the filing, Clinipace indicates that the financing is connected to a merger o... |
| Apr 28, 2011 | Allscript’s Tullman: Community, connectedness will lead to innovation | Tullman said that after a year or two of regularly reading the alerts, he found that he knew much more about the latest research than his son’s doctor. The anecdote made a couple of Tullman’s main points. First, we live in an information ag... |
| Feb 24, 2011 | GSK seeking more pharma partners to fill early stage pipeline (Video) | GlaxoSmithKline’s late stage drug pipeline has many candidates that originally came from the laboratories of other drug companies. But London-based GSK (NYSE:GSK) also aims to more aggressively externalize to its early stage pipeline as wel... |
| Feb 23, 2011 | For biotech investors, late-stage clinical trial failures no longer an option | The CED Biotech/Life Science Conference in Raleigh, N.C. closed with the engaging and entertaining story of MedImmune LLC, the Maryland biotechnology company that was acquired by AstraZeneca plc (NYSE:AZN) for $15.6 billion in 2007.
Former ... |
| Feb 22, 2011 | Early stage biotechs face funding gap as VCs seek surer bets, stronger returns | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recov... |
| Feb 17, 2011 | NC biotech conference ups investment, dealmaking emphasis | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| Sep 20, 2010 | Never Mind the Valley: Here’s Research Triangle | Research Triangle Park is one of the oldest and largest research parks in the United States. Created in the 1950s, the RTP development now spans over 7000 acres and is home to over 170 companies and some 42,000 full-time employees. But the ... |
| Jul 27, 2010 | CED NAMES 25 NORTH CAROLINA COMPANIES TO WATCH | Research Triangle Park, NC - July 27, 2010 |
| Sanofi’s Viehbacher thinks Big Pharma will seek earlier-stage deals. Here’s why | Sanofi (NYSE:SNY) CEO Chris Viehbacher has definite thoughts about how to marry life science ideas with the financing that is the life blood for that innovation. The pharmaceutical giant earlier this year partnered with venture capital firm... |
| The secret sauce of venture philanthropy: Passion and forced collaboration #CEDLSC15 | Last fall, all eyes darted to the concept of venture philanthropy – using venture dollars to empower patient advocacy efforts – when the Cystic Fibrosis Foundation sold its royalty rights to the Vertex drugs it funded for $3.3 billion.
A so... |
| Make a life sciences conference invite only? Open to everyone? Both? | Most life sciences events have an invitation-only event or two. But at the CED Life Science Conference this week there were literally two conferences going on at once: one that everyone could attend and constant, ongoing invitation-only sec... |
| 4 life sciences CEOs on lessons learned the hard way | There are some lessons that no amount of reading can teach an entrepreneur. Sometimes, you just have to learn by doing.
And that goes for companies at all stages, as a panel of CEOs at the CED Life Science Conference shared on Wednesday. Du... |
| 4 tips for life sciences companies seeking foundation funding | Max Wallace, CEO of Accelerate Brain Cancer Cure, uses a football analogy when explaining his foundation’s approach to funding life sciences research.
Large companies aren’t getting into the game, which they see as too risky. But the stakes... |
| CRO Clinipace raises $8M; M&A announcement expected | Clinical research organization Clinipace Worldwide has raised more than $8 million in financing and the company is preparing for an announcement about the funding.
A spokeswoman for Morrisville, North Carolina-based Clinipace said the compa... |
| J&J’s Alex Gorsky on healthcare, globalization and changes to come | Life sciences executives and managers got an exclusive peek into the thinking of Johnson & Johnson’s (NYSE:JNJ) next CEO last week, but those who heard Alex Gorsky speak had idea at the time.
Gorsky was introduced to the nearly 1,000 at... |
| Angel investor involvement growing in North Carolina life sciences startup scene #CEDLSC15 | Angels and high net-worth individuals are making up a growing investment base for North Carolina’s startup sector – an interesting trend that shows that venture dollars are losing their pull in the funding game.
The life sciences sector rai... |
| Life sciences companies make pharma pitches, hope for hits with investors | Life sciences companies presenting at CED’s Life Science Conference largely stuck to script. Prepared remarks. PowerPoint presentations. After 11 minutes on stage, another presenter took their place.
Immunotherapy company Heat Biologics bro... |
| If TearScience does a healthcare IPO, it may be in China | TearScience, the dry eye treatment company fresh off a 510(k) clearance, is starting to explore its options for an initial public offering. But if TearScience does go public, there’s a chance it won’t be on the New York Stock Exchange or NA... |
| Quality over compliance? FDA’s shaking it up. #CEDLSC15 | Change is afoot over at the Food and Drug Administration. Richard Moscicki, deputy center director of science operations for the FDA’s Center for Drug Evaluation and Research, outlined some of the incremental steps at this week’s CED Life S... |
| Allscript’s Tullman: Community, connectedness will lead to innovation | Allscripts (NASDAQ:MDRX) CEO Glen Tullman took a turn for the personal as he wrapped up his speech at the CED Venture Conference in Raleigh, North Carolina this week.
To make a point about patient education, he discussed how he and his wife... |
| Early stage biotechs face funding gap as VCs seek surer bets, stronger returns | Biotechnology companies seeking venture capital got some sobering perspective at the CED Biotech/Life Science Conference this week. Despite the talk of improving market conditions and loosening purse strings leading up to the conference in ... |
| How one Durham-based foundation is investing in North Carolina's entrepreneurs and growing the state's innovation footprint | Thom Ruhe and Roy Cooper. NC IDEA
Redeem now
Kazi Awal/Insider
The NC IDEA foundation supports entrepreneurship and economic development across North Carolina.
Using grants, seed funding, mentoring, and other programs, NC IDEA helps entrepr... |
| GSK seeking more pharma partners to fill early stage pipeline (Video) | GlaxoSmithKline’s late stage drug pipeline has many candidates that originally came from the laboratories of other drug companies. But London-based GSK (NYSE:GSK) also aims to more aggressively externalize to its early stage pipeline as wel... |
| Pharmas, medical device makers set to pitch at CED Life Science conference | Life science companies and investors, let’s make a deal.
The annual CED Life Science Conference kicks off in Raleigh, North Carolina today where small drug developers hope to make the right connection with a big pharmaceutical company or ve... |
| NC biotech conference ups investment, dealmaking emphasis | North Carolina biotech companies, meet the investors. Investors, welcome to North Carolina’s Research Triangle, a bastion of basketball, barbecue and biotech.
Entrepreneurial group CED, formerly known as the Council for Entrepreneurial Deve... |
| Annual CED Life Science Conference features emerging life science companies | This post is sponsored by CED.
CED, the Southeast’s largest entrepreneurial support organization, will feature the Biopharma and Medtech Emerging Company Showcase, showcasing the most promising emerging companies in North Carolina, which wi... |
| Are new life science investors eyeing Research Triangle Park? | Look for new dealflow, new investor faces and new funds in Research Triangle Park throughout the year.
At the moment, the life science investing opportunities can look pretty dry. Intersouth Partners, a Durham, North Carolina venture capita... |
